We are live on ! Find out more
AUXL

AUXILIUM PHARAMCEUTICALS INC
AUXL

Delisted

AUXL was delisted on the 29th of January, 2015.

Back to rankings

1 hedge funds and large institutions have $3.38M invested in AUXILIUM PHARAMCEUTICALS INC in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 156 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 158 → 1 (-157)

100% less capital invested

Capital invested by funds: $2.19B → $3.38M (-$2.19B)

100% less funds holding in top 10

Funds holding in top 10: 8 → 0 (-8)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 156

Holders
1
Holders Change
-157
Holders Change %
-99.37%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
156
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$216M
2
PAI
Palo Alto Investors
California
-$169M
3
PCM
Pentwater Capital Management
Florida
-$130M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$107M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$89.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
JG
51
Jefferies Group
New York
– -$5.66M -164,765 Closed
PCM
52
Prelude Capital Management
New York
– -$5.59M -162,461 Closed
DCM
53
Driehaus Capital Management
Illinois
– -$5.54M -161,000 Closed
Credit Agricole
54
Credit Agricole
France
– -$5.8M -160,333 Closed
HA
55
Havens Advisors
New York
– -$5.5M -160,000 Closed
KM
56
KS Management
New York
– -$5.16M -150,000 Closed
TLCM
57
Tiger Legatus Capital Management
New York
– -$5.16M -150,000 Closed
Walleye Trading
58
Walleye Trading
New York
– -$5.07M -147,450 Closed
KIA
59
King Investment Advisors
Texas
– -$4.99M -144,830 Closed
MF
60
Magnetar Financial
Illinois
– -$4.92M -143,189 Closed
Charles Schwab
61
Charles Schwab
California
– -$4.92M -143,086 Closed
T. Rowe Price Associates
62
T. Rowe Price Associates
Maryland
– -$4.82M -140,100 Closed
HM
63
Harvest Management
New York
– -$4.71M -137,000 Closed
BIM
64
BlackRock Investment Management
Delaware
– -$4.71M -136,871 Closed
AIMCA
65
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$4.68M -136,034 Closed
VAM
66
Visium Asset Management
New York
– -$4.31M -125,284 Closed
UBS Group
67
UBS Group
Switzerland
– -$4.29M -124,741 Closed
Hudson Bay Capital Management
68
Hudson Bay Capital Management
Connecticut
– -$4.12M -119,750 Closed
Macquarie Group
69
Macquarie Group
Australia
– -$4.02M -116,807 Closed
KC
70
Kellner Capital
New York
– -$3.99M -115,900 Closed
Deutsche Bank
71
Deutsche Bank
Germany
– -$3.63M -105,715 Closed
AC
72
Andromeda Capital
New York
– -$3.56M -103,560 Closed
TA
73
Teachers Advisors
New York
– -$3.25M -94,515 Closed
California State Teachers Retirement System (CalSTRS)
74
California State Teachers Retirement System (CalSTRS)
California
– -$3.21M -93,437 Closed
CCS
75
Crosspoint Capital Strategies
California
– -$3.18M -92,484 Closed
1 2
3
4 5

AUXL Hedge Fund Activity: Q1 2015 in Review

1 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q1 2015, worth a combined $3.38M — down 100% from $2.19B a quarter earlier.

Sellers outnumbered buyers: 156 funds closed out of AUXL and 0 opened new positions — a net loss of 156 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Deerfield Management, exiting entirely with an estimated $216M sold.

  • 1 institutional investor held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q1 2015, down from 158 in Q4 2014.
  • Funds reported $3.38M of AUXILIUM PHARAMCEUTICALS INC stock for Q1 2015, down 100% quarter-over-quarter.
  • 0 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q1 2015 and 156 closed out, a net change of -156 holders.
  • The largest AUXILIUM PHARAMCEUTICALS INC seller in Q1 2015 was Deerfield Management, an estimated $216M sold.

Based on aggregated 13F filings for Q1 2015.